Idrissa Traore
Overview
Explore the profile of Idrissa Traore including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
285
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Molia S, Grosbois V, Kamissoko B, Sidibe M, Sissoko K, Traore I, et al.
Avian Dis
. 2017 Jul;
61(2):165-177.
PMID: 28665735
Newcastle disease (ND) is endemic in West Africa, which has also experienced outbreaks of highly pathogenic avian influenza (AI) H5N1 since 2006. We aimed to estimate the prevalence and incidence...
2.
Molia S, Traore I, Kamissoko B, Diakite A, Sidibe M, Sissoko K, et al.
Acta Trop
. 2015 Jun;
150:14-22.
PMID: 26113175
We aimed at characterizing commercial and traditional village poultry farming in Mali, with a focus on practices influencing the risk of transmission of avian influenza and Newcastle disease. Surveys were...
3.
Laurens M, Thera M, Coulibaly D, Ouattara A, Kone A, Guindo A, et al.
PLoS One
. 2013 Nov;
8(11):e79323.
PMID: 24260195
Background: The FMP2.1/AS02A candidate malaria vaccine was tested in a Phase 2 study in Mali. Based on results from the first eight months of follow-up, the vaccine appeared well-tolerated and...
4.
Thera M, Doumbo O, Coulibaly D, Laurens M, Ouattara A, Kone A, et al.
N Engl J Med
. 2011 Sep;
365(11):1004-13.
PMID: 21916638
Background: Blood-stage malaria vaccines are intended to prevent clinical disease. The malaria vaccine FMP2.1/AS02(A), a recombinant protein based on apical membrane antigen 1 (AMA1) from the 3D7 strain of Plasmodium...
5.
Thera M, Doumbo O, Coulibaly D, Laurens M, Kone A, Guindo A, et al.
PLoS One
. 2010 Feb;
5(2):e9041.
PMID: 20140214
Background: The objective was to evaluate the safety and immunogenicity of the AMA1-based malaria vaccine FMP2.1/AS02(A) in children exposed to seasonal falciparum malaria. Methodology/principal Findings: A Phase 1 double blind...